Rosiglitazone and Hyperlipidaemia - a phase IV clinical study of FDA data

Summary:

Hyperlipidaemia is reported as a side effect among people who take Rosiglitazone (rosiglitazone maleate), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Metformin, and have Diabetes.

The phase IV clinical study analyzes which people have Hyperlipidaemia when taking Rosiglitazone. It is created by eHealthMe based on reports of 4,694 people who have side effects when taking Rosiglitazone from the FDA, and is updated regularly.

What is Rosiglitazone?

Rosiglitazone has active ingredients of rosiglitazone maleate. eHealthMe is studying from 4,700 Rosiglitazone users. Check the latest studies of Rosiglitazone.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,419 drugs and 1,410 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,694 people reported to have side effects when taking Rosiglitazone.
Among them, 45 people (0.96%) have Hyperlipidaemia.

Could Rosiglitazone cause Hyperlipidaemia?

Among these 45 people:

How long have people been on Rosiglitazone when they have Hyperlipidaemia? *

What is the gender of people who have Hyperlipidaemia when taking Rosiglitazone? *

female: 48.89 %
male: 51.11 %

What is the age of people who have Hyperlipidaemia when taking Rosiglitazone? *

What are other drugs people take besides Rosiglitazone? *

What are other side effects people have besides Hyperlipidaemia? *

High Blood Pressure: 27 people, 60.00%
Chest Pain: 13 people, 28.89%
Oedema (fluid collection in tissue): 10 people, 22.22%
Heart Attack: 8 people, 17.78%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 13.33%
Fatigue (feeling of tiredness): 5 people, 11.11%
Dyspnea (difficult or laboured breathing): 5 people, 11.11%
Liver Injury: 5 people, 11.11%
Hypoglycemia (low blood sugar): 5 people, 11.11%
Death: 5 people, 11.11%

What are the existing conditions these people have? *

Diabetes: 31 people, 68.89%
Type 2 Diabetes: 4 people, 8.89%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 4.44%
High Blood Pressure: 2 people, 4.44%
Blood Glucose Abnormal: 2 people, 4.44%
Blood Glucose Increased: 2 people, 4.44%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 2 people, 4.44%
Dizziness: 2 people, 4.44%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 4.44%
Vaginal Infection: 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Rosiglitazone and have Hyperlipidaemia?

- Check whether Hyperlipidaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosiglitazone:

Rosiglitazone (4,700 reports)

Hyperlipidaemia treatments and more:

Hyperlipidaemia (86,394 reports)

Browse all side effects of Rosiglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,419 drugs)

Browse all the conditions that are associated with Hyperlipidaemia:

Hyperlipidaemia (1,410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosiglitazone maleate (the active ingredients of Rosiglitazone) and Rosiglitazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.